Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	chromatin binding	FLI1 TCF7L2 MLLT10 RUNX1 MBD6 ARID1A AHDC1 HESX1 TRIM33 NEUROD1 PYGO2 AUTS2 ASXL2 RERE CABIN1 TOX2	1.76e-07	739	90	16	GO:0003682
GeneOntologyBiologicalProcess	epithelium development	NRG1 TCF7L2 SPINT1 NUP210L CECR2 TMEM79 RUNX1 ARID1A NSUN2 HESX1 AXIN2 FOXP4 TNFSF11 NEUROD1 PYGO2 PKP3 LRP6 KDF1 NOTCH2	1.30e-05	1469	89	19	GO:0060429
GeneOntologyBiologicalProcess	embryo development	TCF7L2 SPINT1 CECR2 RUNX1 ARID1A NSUN2 AHDC1 HESX1 AXIN2 FOXP4 NEUROD1 SEC24C KIAA1217 ETNK2 LRP6 ASXL2 KDF1 NOTCH2	3.52e-05	1437	89	18	GO:0009790
GeneOntologyBiologicalProcess	embryonic morphogenesis	TCF7L2 SPINT1 CECR2 ARID1A AHDC1 HESX1 FOXP4 NEUROD1 LRP6 ASXL2 KDF1 NOTCH2	5.51e-05	713	89	12	GO:0048598
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	FLI1 TCF7L2 CEBPE MLLT10 NR4A1 RUNX1 IFI16 TNFSF11 NEUROD1 AUTS2 LRP6 ASXL2 ELK3 TAF4 MGA TOX2 NOTCH2	8.11e-05	1390	89	17	GO:0045944
GeneOntologyBiologicalProcess	tissue morphogenesis	NRG1 SPINT1 CECR2 TMEM79 RUNX1 ARID1A AHDC1 HESX1 MYLK2 LRP6 KDF1 NOTCH2	8.92e-05	750	89	12	GO:0048729
GeneOntologyBiologicalProcess	chordate embryonic development	TCF7L2 SPINT1 CECR2 RUNX1 ARID1A NSUN2 AXIN2 SEC24C KIAA1217 ETNK2 LRP6 ASXL2 NOTCH2	1.33e-04	906	89	13	GO:0043009
GeneOntologyBiologicalProcess	sex differentiation	TCF7L2 NUP210L DACH1 RUNX1 HESX1 LRP6 TAF4 MERTK	1.41e-04	352	89	8	GO:0007548
MousePheno	abnormal embryonic tissue morphology	TCF7L2 CECR2 DZIP1 MLLT10 RUNX1 MBD6 ARID1A HESX1 AXIN2 TRIM33 FOXP4 PYGO2 PRRC2C KIAA1217 AUTS2 LRP6 RERE MGA	1.22e-05	1116	73	18	MP:0002085
MousePheno	abnormal neural tube morphology	CECR2 DZIP1 MLLT10 MBD6 ARID1A HESX1 AXIN2 FOXP4 PYGO2 PRRC2C LRP6 RERE	5.05e-05	591	73	12	MP:0002151
MousePheno	perinatal lethality, complete penetrance	NRG1 TCF7L2 DACH1 ARID1A AHDC1 HESX1 NEUROD1 PYGO2 AUTS2 LRP6 RERE KDF1 NOTCH2	7.07e-05	712	73	13	MP:0011089
MousePheno	facial cleft	PIGN CECR2 MLLT10 HESX1	9.46e-05	46	73	4	MP:0008797
MousePheno	decreased forebrain size	PIGN ARID1A HESX1 LRP6	1.03e-04	47	73	4	MP:0012138
MousePheno	microphthalmia	PIGN ZC3H12B MLLT10 HESX1 AXIN2 PYGO2 LRP6 RERE NOTCH2	1.07e-04	362	73	9	MP:0001297
MousePheno	abnormal eye size	PIGN ZC3H12B MLLT10 HESX1 AXIN2 PYGO2 LRP6 RERE NOTCH2	1.39e-04	375	73	9	MP:0002697
MousePheno	abnormal forebrain size	PIGN ARID1A HESX1 LRP6	1.42e-04	51	73	4	MP:0012137
MousePheno	abnormal neural tube closure	CECR2 MBD6 ARID1A AXIN2 FOXP4 PYGO2 PRRC2C LRP6 RERE	1.48e-04	378	73	9	MP:0003720
MousePheno	embryonic lethality during organogenesis	FLI1 NRG1 SPINT1 ATG13 RBMS1 DZIP1 RUNX1 ARID1A AXIN2 FOXP4 RERE TAF4 CABIN1 NOTCH2	1.49e-04	876	73	14	MP:0006207
MousePheno	forebrain hypoplasia	PIGN ARID1A LRP6	2.56e-04	24	73	3	MP:0000784
Domain	NPIP	NPIPB8 NPIPB6 NPIPA2	4.46e-05	14	95	3	IPR009443
Pubmed	Human transcription factor protein interaction networks.	FLI1 TCF7L2 CNOT10 RBMS1 DACH1 MLLT10 MBD6 ARID1A NSUN2 TAB3 KIAA1671 TRIM33 FOXP4 PYGO2 UBAP2L PRRC2C AUTS2 LRP6 ASXL2 ELK3 RERE TAF4 CABIN1 MGA	8.62e-13	1429	97	24	35140242
Pubmed	Interaction network of human early embryonic transcription factors.	FLI1 TCF7L2 MBD6 ARID1A AHDC1 KIAA1671 TRIM33 FOXP4 PYGO2 AUTS2 ASXL2 RERE TAF4 MGA	1.15e-12	351	97	14	38297188
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	TCF7L2 MAP1A MLLT10 LMTK3 KIAA1671 SETBP1 CYP26C1 WDR90 BSN MGA	3.63e-07	430	97	10	35044719
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	TCF7L2 ATG13 WASF3 ARID1A AHDC1 KIAA1671 FOXP4 UBAP2L PKP3 KIAA1217 SETBP1 AUTS2 CACNA1H ELK3 RERE TAF4 NOTCH2	7.32e-07	1489	97	17	28611215
Pubmed	A census of human transcription factors: function, expression and evolution.	FLI1 TCF7L2 CEBPE NR4A1 RUNX1 HESX1 FOXP4 NEUROD1 SETBP1 ELK3 RERE MGA TOX2	1.48e-06	908	97	13	19274049
Pubmed	Stringent requirement of a proper level of canonical WNT signalling activity for head formation in mouse embryo.	TCF7L2 HESX1 LRP6	3.41e-06	11	97	3	21228006
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	DOCK4 DSC2 ATG13 DZIP1 NCKAP5L TAB3 MYLK2 KIAA1671 PRRC2C KIAA1217 NOTCH2 OTOG	5.10e-06	861	97	12	36931259
Pubmed	The genetics of nodal marginal zone lymphoma.	PTPRD NOTCH2	7.70e-06	2	97	2	27335277
Pubmed	DACH1 negatively regulates the human RANK ligand gene expression in stromal/preosteoblast cells.	DACH1 TNFSF11	7.70e-06	2	97	2	17891780
Pubmed	The genome-wide impact of trisomy 21 on DNA methylation and its implications for hematopoiesis.	FLI1 RUNX1	7.70e-06	2	97	2	33547282
Pubmed	Gene conversion and purifying selection of a placenta-specific ERV-V envelope gene during simian evolution.	ERVV-2 ERVV-1	7.70e-06	2	97	2	18826608
Pubmed	Genotypes and Haplotypes in the AXIN2 and TCF7L2 Genes are Associated With Susceptibility and With Clinicopathological Characteristics in Breast Cancer Patients.	TCF7L2 AXIN2	7.70e-06	2	97	2	35996498
Pubmed	Runx1 repression by histone deacetylation is critical for Setbp1-induced mouse myeloid leukemia development.	RUNX1 SETBP1	7.70e-06	2	97	2	26205084
Pubmed	Frameshift mutations of Wnt pathway genes AXIN2 and TCF7L2 in gastric carcinomas with high microsatellite instability.	TCF7L2 AXIN2	7.70e-06	2	97	2	18755497
Pubmed	Association of NRG1 and AUTS2 genetic polymorphisms with Hirschsprung disease in a South Chinese population.	NRG1 AUTS2	7.70e-06	2	97	2	29377512
Pubmed	Plakophilin3 increases desmosome assembly, size and stability by increasing expression of desmocollin2.	DSC2 PKP3	7.70e-06	2	97	2	29146182
Pubmed	Enrichment of FLI1 and RUNX1 mutations in families with excessive bleeding and platelet dense granule secretion defects.	FLI1 RUNX1	7.70e-06	2	97	2	24100448
Pubmed	Differential evolutionary fate of an ancestral primate endogenous retrovirus envelope gene, the EnvV syncytin, captured for a function in placentation.	ERVV-2 ERVV-1	7.70e-06	2	97	2	23555306
Pubmed	Low Vitamin-D Levels Combined with PKP3-SIGIRR-TMEM16J Host Variants Is Associated with Tuberculosis and Death in HIV-Infected and -Exposed Infants.	ANO9 PKP3	7.70e-06	2	97	2	26872154
Pubmed	Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development.	FLI1 RUNX1	7.70e-06	2	97	2	19470763
Pubmed	An Oct4-centered protein interaction network in embryonic stem cells.	ARID1A TRIM33 FOXP4 TAF4 CABIN1 MGA	7.71e-06	167	97	6	20362541
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	ARID1A AHDC1 TRIM33 FOXP4 PYGO2 RERE MGA	1.06e-05	268	97	7	33640491
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	FLI1 TCF7L2 CEBPE DACH1 RUNX1 ARID1A IFI16 NSUN2 AHDC1 TRIM33 PRRC2C ASXL2 TAF4	1.21e-05	1103	97	13	34189442
Pubmed	Prediction of the coding sequences of unidentified human genes. VIII. 78 new cDNA clones from brain which code for large proteins in vitro.	SETBP1 AUTS2 BSN PLXNB1	1.39e-05	52	97	4	9455477
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CBLL1 GRIA2 LMTK3 PTPRD SEC24C UBAP2L PRRC2C KIAA1217 TAF4 BSN CABIN1 MGA	1.56e-05	963	97	12	28671696
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	TCF7L2 CECR2 ARID1A NCKAP5L TRIM33 FOXP4 AUTS2 MGA	1.63e-05	398	97	8	35016035
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CECR2 RNF44 DZIP1 TRIM33 SETBP1 AUTS2 WDR90 BSN PLXNB1	1.78e-05	529	97	9	14621295
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DOCK4 ATG13 SEC24C UBAP2L PRRC2C CACNA1H ASXL2 RERE	1.91e-05	407	97	8	12693553
Pubmed	In vivo transcriptional governance of hair follicle stem cells by canonical Wnt regulators.	TCF7L2 AXIN2	2.31e-05	3	97	2	24463605
Pubmed	NF-E2, FLI1 and RUNX1 collaborate at areas of dynamic chromatin to activate transcription in mature mouse megakaryocytes.	FLI1 RUNX1	2.31e-05	3	97	2	27457419
Pubmed	Common polymorphisms in the PKP3-SIGIRR-TMEM16J gene region are associated with susceptibility to tuberculosis.	ANO9 PKP3	2.31e-05	3	97	2	22223854
Pubmed	ASXL2 mutations are frequently found in pediatric AML patients with t(8;21)/ RUNX1-RUNX1T1 and associated with a better prognosis.	RUNX1 ASXL2	2.31e-05	3	97	2	28063196
Pubmed	LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1.	AXIN2 LRP6	2.31e-05	3	97	2	23302695
Pubmed	Myeloid receptor CD36 is required for early phagocytosis of myocardial infarcts and induction of Nr4a1-dependent mechanisms of cardiac repair.	NR4A1 MERTK	2.31e-05	3	97	2	28860151
Pubmed	Colorectal cancer and genetic alterations in the Wnt pathway.	TCF7L2 AXIN2	2.31e-05	3	97	2	17143297
Pubmed	Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling.	TCF7L2 AXIN2	2.31e-05	3	97	2	11940574
Pubmed	Desmocollin-2 alone forms functional desmosomal plaques, with the plaque formation requiring the juxtamembrane region and plakophilins.	DSC2 PKP3	2.31e-05	3	97	2	25972099
Pubmed	Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/RUNX1-RUNX1T1 chromosomal translocations.	RUNX1 ASXL2	2.31e-05	3	97	2	24973361
Pubmed	Chromatin effector Pygo2 regulates mammary tumor initiation and heterogeneity in MMTV-Wnt1 mice.	AXIN2 PYGO2	2.31e-05	3	97	2	23334328
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	MAP1A DACH1 IFI16 AHDC1 TRIM33 UBAP2L TAF4 MGA	3.55e-05	444	97	8	34795231
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	DOCK4 MAP1A ARID1A NCKAP5L KIAA1671 TRIM33 PRRC2C KIAA1217 BSN	4.05e-05	588	97	9	38580884
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	TCF7L2 ARID1A AHDC1 TRIM33 PYGO2 PRRC2C PKP3 AUTS2	4.35e-05	457	97	8	32344865
Pubmed	TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8+ T cell exhaustion.	NR4A1 TOX2	4.60e-05	4	97	2	31152140
Pubmed	Regulation of aldosterone and cortisol production by the transcriptional repressor neuron restrictive silencer factor.	CYP11B2 CACNA1H	4.60e-05	4	97	2	19342457
Pubmed	The association of Notch2 and NF-kappaB accelerates RANKL-induced osteoclastogenesis.	TNFSF11 NOTCH2	4.60e-05	4	97	2	18710934
Pubmed	LRP6 enhances glucose metabolism by promoting TCF7L2-dependent insulin receptor expression and IGF receptor stabilization in humans.	TCF7L2 LRP6	4.60e-05	4	97	2	23395167
Pubmed	Mutations in WNT10B Are Identified in Individuals with Oligodontia.	AXIN2 LRP6	4.60e-05	4	97	2	27321946
Pubmed	Microtubule-associated protein light chain 2 is a stargazin-AMPA receptor complex-interacting protein in vivo.	MAP1A GRIA2	4.60e-05	4	97	2	15136571
Pubmed	TRPM1 is a component of the retinal ON bipolar cell transduction channel in the mGluR6 cascade.	GRM6 BSN	4.60e-05	4	97	2	19966281
Pubmed	SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer.	TCF7L2 LRP6	4.60e-05	4	97	2	23306204
Pubmed	TCF7L2 (Transcription Factor 7-Like 2) Regulation of GATA6 (GATA-Binding Protein 6)-Dependent and -Independent Vascular Smooth Muscle Cell Plasticity and Intimal Hyperplasia.	TCF7L2 LRP6	4.60e-05	4	97	2	30567484
Pubmed	Dentate gyrus morphogenesis is regulated by β-catenin function in hem-derived fimbrial glia.	TCF7L2 AXIN2 NEUROD1	4.63e-05	25	97	3	36196585
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	DSC2 MAP1A CECR2 ARID1A NCKAP5L KIAA1671 TRIM33 FOXP4 RERE TAF4 MGA NOTCH2	6.52e-05	1116	97	12	31753913
Pubmed	WNT5A signaling affects pituitary gland shape.	TCF7L2 HESX1 NOTCH2	7.29e-05	29	97	3	15037319
Pubmed	Transcription and Signaling Regulators in Developing Neuronal Subtypes of Mouse and Human Enteric Nervous System.	NRG1 TCF7L2 RUNX1 PTPRD PLXNB1 NOTCH2	7.60e-05	251	97	6	29031500
Pubmed	TGFβ-activated kinase 1 (TAK1)-binding proteins (TAB) 2 and 3 negatively regulate autophagy.	ATG13 TAB3	7.66e-05	5	97	2	21976705
Pubmed	The nuclear orphan receptor Nr4a2 induces Foxp3 and regulates differentiation of CD4+ T cells.	NR4A1 RUNX1	7.66e-05	5	97	2	21468021
Pubmed	IL-1 receptor accessory protein-like 1 associated with mental retardation and autism mediates synapse formation by trans-synaptic interaction with protein tyrosine phosphatase δ.	PTPRD BSN	7.66e-05	5	97	2	21940441
Pubmed	Notch expression in developing olfactory neuroepithelium.	NEUROD1 NOTCH2	7.66e-05	5	97	2	15076712
Pubmed	Interleukin-1 receptor accessory protein organizes neuronal synaptogenesis as a cell adhesion molecule.	PTPRD BSN	7.66e-05	5	97	2	22357843
Pubmed	Wnt/β-catenin signaling modulates corneal epithelium stratification via inhibition of Bmp4 during mouse development.	AXIN2 LRP6	7.66e-05	5	97	2	26443636
Pubmed	Developmental dependence on NurRE and EboxNeuro for expression of pituitary proopiomelanocortin.	NR4A1 NEUROD1	7.66e-05	5	97	2	18388149
Pubmed	Activation of Wnt signaling reduces ipsilaterally projecting retinal ganglion cells in pigmented retina.	AXIN2 LRP6 NOTCH2	8.93e-05	31	97	3	30254141
Pubmed	Genetic interaction between the homeobox transcription factors HESX1 and SIX3 is required for normal pituitary development.	HESX1 AXIN2 NEUROD1	8.93e-05	31	97	3	18775421
Pubmed	Wnt and Neuregulin1/ErbB signalling extends 3D culture of hormone responsive mammary organoids.	NRG1 AXIN2	1.15e-04	6	97	2	27782124
Pubmed	Reactivation of codogenic endogenous retroviral (ERV) envelope genes in human endometrial carcinoma and prestages: Emergence of new molecular targets.	ERVV-2 ERVV-1	1.15e-04	6	97	2	23085571
Pubmed	A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells.	TCF7L2 AXIN2	1.15e-04	6	97	2	17072303
Pubmed	Role for Runx1 in the proliferation and neuronal differentiation of selected progenitor cells in the mammalian nervous system.	RUNX1 NEUROD1	1.15e-04	6	97	2	15728845
Pubmed	Genome-wide analysis of simultaneous GATA1/2, RUNX1, FLI1, and SCL binding in megakaryocytes identifies hematopoietic regulators.	FLI1 RUNX1	1.15e-04	6	97	2	21571218
Pubmed	Macrophage Wnt7b is critical for kidney repair and regeneration.	AXIN2 LRP6	1.15e-04	6	97	2	20160075
Pubmed	Wnt5a is essential for hippocampal dendritic maintenance and spatial learning and memory in adult mice.	GRIA2 AXIN2 NEUROD1	1.18e-04	34	97	3	28069946
Pubmed	Context-specific function of the LIM homeobox 1 transcription factor in head formation of the mouse embryo.	TCF7L2 HESX1 AXIN2	1.29e-04	35	97	3	25977363
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	DOCK4 NRG1 CNOT10 TRIM33 ZNF500 ASXL2 TAF4 MGA OTOG	1.35e-04	689	97	9	36543142
Pubmed	Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells.	CEBPE RUNX1 ARID1A IFI16 CABIN1	1.46e-04	178	97	5	27637333
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	DACH1 ARID1A TAB3 KIAA1671 UBAP2L PRRC2C TAF4 MGA	1.55e-04	549	97	8	38280479
Pubmed	RSPO2 and RANKL signal through LGR4 to regulate osteoclastic premetastatic niche formation and bone metastasis.	TNFSF11 LRP6	1.60e-04	7	97	2	34847079
Pubmed	Wt1 and β-catenin cooperatively regulate diaphragm development in the mouse.	TCF7L2 AXIN2	1.60e-04	7	97	2	26278035
Pubmed	Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia.	FLI1 RUNX1	1.60e-04	7	97	2	23327922
Pubmed	Mutations in Bcl9 and Pygo genes cause congenital heart defects by tissue-specific perturbation of Wnt/β-catenin signaling.	AXIN2 PYGO2	1.60e-04	7	97	2	30366904
Pubmed	Androgen upregulates NR4A1 via the TFAP2A and ETS signaling networks.	FLI1 NR4A1	1.60e-04	7	97	2	31146003
Pubmed	miR-29a/b1 Inhibits Hair Follicle Stem Cell Lineage Progression by Spatiotemporally Suppressing WNT and BMP Signaling.	AXIN2 LRP6	1.60e-04	7	97	2	31747615
Pubmed	Retinoblastoma and the related pocket protein p107 act as coactivators of NeuroD1 to enhance gene transcription.	NR4A1 NEUROD1	1.60e-04	7	97	2	15701640
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	MAP1A NCKAP5L TRIM33 MGA NOTCH2	1.71e-04	184	97	5	32908313
Pubmed	Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms.	TCF7L2 RBMS1 NOTCH2	2.08e-04	41	97	3	20889853
Pubmed	Rab11-FIP1 and Rab11-FIP5 Regulate pIgR/pIgA Transcytosis through TRIM21-Mediated Polyubiquitination.	MYRFL SEC24C NOTCH2	2.08e-04	41	97	3	34638806
Pubmed	Etv2/ER71 induces vascular mesoderm from Flk1+PDGFRα+ primitive mesoderm.	FLI1 RUNX1	2.13e-04	8	97	2	21911838
Pubmed	Synaptic profiles during neurite extension, refinement and retraction in the developing cochlea.	GRIA2 BSN	2.13e-04	8	97	2	23217150
Pubmed	CD24 is expressed by myofiber synaptic nuclei and regulates synaptic transmission.	NRG1 MYLK2	2.13e-04	8	97	2	16606832
Pubmed	Genetic utility of broadly defined bipolar schizoaffective disorder as a diagnostic concept.	AUTS2 BSN	2.13e-04	8	97	2	19567891
Pubmed	Syncytins expressed in human placental trophoblast.	ERVV-2 ERVV-1	2.13e-04	8	97	2	33504453
Pubmed	Essential role for ADAM19 in cardiovascular morphogenesis.	NRG1 TNFSF11	2.13e-04	8	97	2	14673146
Pubmed	Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation.	TCF7L2 AXIN2	2.13e-04	8	97	2	22056988
Pubmed	Runx1 controls auditory sensory neuron diversity in mice.	GRIA2 RUNX1	2.13e-04	8	97	2	36800995
Pubmed	Nuclear receptor NR4A1 promotes breast cancer invasion and metastasis by activating TGF-β signalling.	NR4A1 AXIN2	2.13e-04	8	97	2	24584437
Pubmed	Insm1 controls development of pituitary endocrine cells and requires a SNAG domain for function and for recruitment of histone-modifying factors.	HESX1 NEUROD1 NOTCH2	2.39e-04	43	97	3	24227653
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	CBLL1 TCF7L2 NR4A1 RUNX1 ARID1A IFI16 AHDC1 PKP3 ASXL2 TAF4 CABIN1 MGA	2.58e-04	1294	97	12	30804502
Pubmed	Efficient conditional and promoter-specific in vivo expression of cDNAs of choice by taking advantage of recombinase-mediated cassette exchange using FlEx gene traps.	AHDC1 KIAA1217	2.74e-04	9	97	2	20139417
Pubmed	MAP3K1 functionally interacts with Axin1 in the canonical Wnt signalling pathway.	AXIN2 LRP6	2.74e-04	9	97	2	20128690
Pubmed	Wnt3 function in the epiblast is required for the maintenance but not the initiation of gastrulation in mice.	HESX1 AXIN2	2.74e-04	9	97	2	23085236
Pubmed	Specification of embryonic stem cell-derived tissues into eye fields by Wnt signaling using rostral diencephalic tissue-inducing culture.	TCF7L2 AXIN2	2.74e-04	9	97	2	27151576
Interaction	TLE3 interactions	CBLL1 TCF7L2 CECR2 MLLT10 RUNX1 ARID1A AHDC1 PYGO2 AUTS2 ASXL2 ELK3 RERE TAF4	1.59e-08	376	92	13	int:TLE3
Interaction	ERG interactions	FLI1 TCF7L2 MLLT10 ARID1A TRIM33 FOXP4 PTPRD PYGO2 ASXL2 RERE	7.35e-08	223	92	10	int:ERG
Interaction	EGR2 interactions	FLI1 TCF7L2 ARID1A AHDC1 TRIM33 FOXP4 PYGO2 RERE MGA	8.77e-08	171	92	9	int:EGR2
Interaction	CRX interactions	FLI1 TCF7L2 ARID1A TRIM33 FOXP4 PYGO2 ASXL2 RERE MGA	2.43e-06	254	92	9	int:CRX
Interaction	HNF1B interactions	TCF7L2 DACH1 MLLT10 MBD6 ARID1A ASXL2 CABIN1 MGA	2.55e-06	190	92	8	int:HNF1B
Interaction	FOXI1 interactions	TCF7L2 MLLT10 ARID1A TRIM33 FOXP4 ASXL2	3.99e-06	92	92	6	int:FOXI1
Interaction	FEV interactions	TCF7L2 DACH1 MLLT10 ARID1A FOXP4 ASXL2 TAF4 MGA	4.17e-06	203	92	8	int:FEV
Interaction	HCFC1 interactions	ATG13 RUNX1 MBD6 UBAP2L PRRC2C ASXL2 RERE TAF4 MGA	7.76e-06	293	92	9	int:HCFC1
Interaction	TLX1 interactions	TCF7L2 DACH1 ARID1A FOXP4 PYGO2 AUTS2 ASXL2	1.55e-05	175	92	7	int:TLX1
Interaction	ELK3 interactions	TCF7L2 DACH1 FOXP4 ELK3 TAF4 MGA	1.85e-05	120	92	6	int:ELK3
Interaction	ZFP36 interactions	CNOT10 RBMS1 NCKAP5L KIAA1671 UBAP2L PRRC2C NYNRIN	1.93e-05	181	92	7	int:ZFP36
Interaction	PAX7 interactions	FLI1 TCF7L2 DACH1 ARID1A FOXP4 PYGO2	2.22e-05	124	92	6	int:PAX7
Interaction	SOX7 interactions	TCF7L2 CECR2 ARID1A TRIM33 FOXP4	3.67e-05	82	92	5	int:SOX7
Interaction	HNF4A interactions	TCF7L2 DACH1 ARID1A TRIM33 ASXL2 TAF4 CABIN1 MGA	3.75e-05	275	92	8	int:HNF4A
Interaction	CNOT3 interactions	MAP1A CNOT10 RBMS1 RUNX1 TAB3 UBAP2L PRRC2C	4.56e-05	207	92	7	int:CNOT3
Interaction	GSC interactions	FLI1 TCF7L2 FOXP4 AUTS2 RERE	4.89e-05	87	92	5	int:GSC
Interaction	NFIC interactions	TCF7L2 DACH1 ARID1A NSUN2 FOXP4 ELK3 MGA	5.00e-05	210	92	7	int:NFIC
Interaction	FXR1 interactions	RBMS1 CECR2 GRIA2 LMTK3 IFI16 AXIN2 KIAA1671 KIAA1549L SEC24C UBAP2L PRRC2C PKP3	5.99e-05	679	92	12	int:FXR1
Interaction	TCF12 interactions	TCF7L2 RUNX1 TRIM33 NEUROD1 TAF4 MGA	6.01e-05	148	92	6	int:TCF12
Interaction	SP7 interactions	FLI1 TCF7L2 ARID1A TRIM33 FOXP4 PYGO2 RERE MGA	7.59e-05	304	92	8	int:SP7
Interaction	LHX1 interactions	TCF7L2 ARID1A FOXP4 PYGO2 MGA	1.09e-04	103	92	5	int:LHX1
Interaction	NUP35 interactions	TCF7L2 ARID1A IFI16 AHDC1 TRIM33 PYGO2 PRRC2C PKP3 AUTS2	1.38e-04	424	92	9	int:NUP35
Interaction	FXR2 interactions	CNOT10 RBMS1 CECR2 IFI16 AXIN2 KIAA1671 UBAP2L PRRC2C KIAA1217	1.53e-04	430	92	9	int:FXR2
Interaction	AR interactions	TCF7L2 RUNX1 ARID1A IFI16 NSUN2 AHDC1 TRIM33 FOXP4 PYGO2 UBAP2L KIAA1217 TNS4 RERE MGA	1.56e-04	992	92	14	int:AR
Interaction	HELZ interactions	CNOT10 RBMS1 IFI16 KIAA1671 UBAP2L PRRC2C WDR90	1.76e-04	257	92	7	int:HELZ
Interaction	ELF4 interactions	RUNX1 TRIM33 ASXL2 TAF4 MGA	1.84e-04	115	92	5	int:ELF4
Interaction	ALG13 interactions	TCF7L2 RBMS1 ARID1A UBAP2L PRRC2C RERE	1.93e-04	183	92	6	int:ALG13
Interaction	SOX2 interactions	FLI1 TCF7L2 DSC2 MAP1A RBMS1 DACH1 RUNX1 ARID1A AHDC1 KIAA1671 TRIM33 FOXP4 PYGO2 PKP3 KIAA1217 TNS4 MAGEC1	2.16e-04	1422	92	17	int:SOX2
Interaction	MYOD1 interactions	TCF7L2 RUNX1 ARID1A TRIM33 CABIN1 MGA	2.64e-04	194	92	6	int:MYOD1
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500	DOCK4 FLI1 DSC2 MAP1A CD248 RBMS1 MUC16 RUNX1 HMCN1 NYNRIN KIAA1217 ETNK2	3.22e-07	418	94	12	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_500	DOCK4 FLI1 DSC2 CD248 RBMS1 MUC16 DZIP1 NR4A1 RUNX1 NYNRIN KIAA1217 ETNK2	3.66e-07	423	94	12	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	DOCK4 DSC2 MAP1A CD248 MUC16 ZC3H12B NR4A1 FOXP4 PTPRD HMCN1 NYNRIN KIAA1217 ETNK2 CACNA1H MERTK NOTCH2	3.72e-07	793	94	16	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000	DOCK4 FLI1 DSC2 MAP1A CD248 RBMS1 MUC16 DZIP1 NR4A1 RUNX1 PTPRD HMCN1 NYNRIN KIAA1217 ETNK2 NOTCH2	6.49e-07	827	94	16	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000	DOCK4 DSC2 CD248 RBMS1 MUC16 ZC3H12B DZIP1 NR4A1 RUNX1 AXIN2 PTPRD HMCN1 NYNRIN ETNK2 NOTCH2	1.71e-06	783	94	15	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500	DOCK4 DSC2 CD248 MUC16 NR4A1 RUNX1 AXIN2 HMCN1 NYNRIN ETNK2	4.11e-06	357	94	10	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000	PIGN DOCK4 DSC2 CD248 MUC16 DZIP1 NR4A1 RUNX1 AXIN2 PTPRD HMCN1 NYNRIN ETNK2 MERTK	4.55e-06	740	94	14	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_200	DOCK4 DSC2 CD248 MUC16 RUNX1 HMCN1 ETNK2	5.10e-06	152	94	7	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_200
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000	DOCK4 FLI1 DSC2 CD248 RBMS1 MUC16 ZC3H12B DZIP1 NR4A1 RUNX1 HMCN1 NYNRIN KIAA1217 ETNK2	1.69e-05	831	94	14	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_100	DOCK4 DSC2 MUC16 RUNX1 HMCN1	2.82e-05	80	94	5	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_100
CoexpressionAtlas	dev gonad_e11.5_M_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_100	DOCK4 DSC2 RUNX1	4.51e-05	16	94	3	gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_k2_100
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000	DOCK4 DSC2 MAP1A CD248 MUC16 DZIP1 NR4A1 RUNX1 AXIN2 HMCN1 NYNRIN KIAA1217 ETNK2	4.85e-05	797	94	13	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_1000	TCF7L2 DSC2 SPINT1 TMEM79 DACH1 NR4A1 RUNX1 TAB3 PTPRD PKP3 AUTS2 TNS4 PLXNB1	5.04e-05	800	94	13	gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000
CoexpressionAtlas	dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_100	DOCK4 DSC2 MUC16 NR4A1 ETNK2	5.54e-05	92	94	5	gudmap_dev gonad_e11.5_M_GonMes_Sma_100
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500	DOCK4 DSC2 CD248 MUC16 RUNX1 AXIN2 HMCN1 NYNRIN ETNK2	5.60e-05	388	94	9	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500	NRG1 DSC2 SPINT1 CECR2 RUNX1 KIAA1549L PKP3 KDF1 TOX2 PLXNB1	6.79e-05	495	94	10	Facebase_RNAseq_e10.5_Olfactory Pit_500
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_200	DOCK4 DSC2 MUC16 NR4A1 RUNX1 HMCN1	7.32e-05	158	94	6	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_200
CoexpressionAtlas	facebase_RNAseq_e10.5_OlfacPit_2500_K1	ANO9 DSC2 SPINT1 CORO2A RUNX1 PKP3 KIAA1217 KDF1 PLXNB1	7.35e-05	402	94	9	facebase_RNAseq_e10.5_OlfacPit_2500_K1
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_500	FLI1 RBMS1 HMCN1	9.07e-05	20	94	3	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k3_500
CoexpressionAtlas	dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000	DOCK4 DSC2 MAP1A CD248 MUC16 ZC3H12B NR4A1 RUNX1 HMCN1 NYNRIN KIAA1217 ETNK2 MERTK	1.02e-04	858	94	13	gudmap_dev gonad_e11.5_F_GonMes_Sma_1000
CoexpressionAtlas	facebase_RNAseq_e9.5_OlfPlac_2500_K2	ANO9 DSC2 SPINT1 TMEM79 PKP3 KIAA1217 KDF1 PLXNB1	1.05e-04	328	94	8	facebase_RNAseq_e9.5_OlfPlac_2500_K2
CoexpressionAtlas	dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_500	DOCK4 DSC2 CD248 MUC16 NR4A1 RUNX1 KIAA1217 ETNK2 MERTK	1.27e-04	432	94	9	gudmap_dev gonad_e11.5_M_GonMes_Sma_500
CoexpressionAtlas	dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_200	DOCK4 DSC2 MUC16 NR4A1 RUNX1 ETNK2	1.33e-04	176	94	6	gudmap_dev gonad_e11.5_M_GonMes_Sma_200
CoexpressionAtlas	dev gonad_e13.5_F_SupCellPrec_Sry_k-means-cluster#4_top-relative-expression-ranked_100	DOCK4 DSC2 RUNX1	1.40e-04	23	94	3	gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_k4_100
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	MAP1A CD248 MUC16 ZC3H12B NR4A1 PTPRD HMCN1 NYNRIN KIAA1217 ETNK2 CACNA1H NOTCH2	1.61e-04	777	94	12	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_200	DOCK4 DSC2 MUC16 NR4A1 RUNX1 ETNK2	1.64e-04	183	94	6	gudmap_dev gonad_e11.5_F_GonMes_Sma_200
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#2_top-relative-expression-ranked_1000	FLI1 RBMS1 NR4A1 HMCN1	1.65e-04	62	94	4	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k2_1000
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000	DOCK4 DSC2 MAP1A CD248 MUC16 ZC3H12B DZIP1 NR4A1 RUNX1 HMCN1 NYNRIN ETNK2	2.04e-04	797	94	12	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500	CD248 MUC16 NR4A1 HMCN1 NYNRIN	2.10e-04	122	94	5	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500
CoexpressionAtlas	dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_100	DOCK4 DSC2 RUNX1	2.28e-04	27	94	3	gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k1_100
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000	TCF7L2 DSC2 DACH1 GRIA2 IFI16 AXIN2 HMCN1 AUTS2	2.70e-04	377	94	8	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k2
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_500	DOCK4 DSC2 CD248 MUC16 NR4A1 RUNX1 HMCN1 ETNK2	3.11e-04	385	94	8	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_500
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500	NRG1 TCF7L2 DSC2 SPINT1 CECR2 RNF44 HESX1 KIAA1549L TOX2	3.48e-04	495	94	9	Facebase_RNAseq_e8.5_Floor Plate_500
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000	NRG1 TCF7L2 MAP1A SPINT1 CECR2 RNF44 RUNX1 HESX1 KIAA1549L RTL3 PKP3 CACNA1H TOX2	3.60e-04	976	94	13	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_200	DOCK4 MUC16 RUNX1 HMCN1 ETNK2	3.60e-04	137	94	5	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000	FLI1 DSC2 DACH1 GRIA2 DZIP1 RUNX1 IFI16 AXIN2 HMCN1 AUTS2 ASXL2 ELK3	3.67e-04	850	94	12	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000
CoexpressionAtlas	mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K1	ANO9 DSC2 SPINT1 CORO2A TMEM79 NR4A1 PKP3 TNS4	4.15e-04	402	94	8	mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K1
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_100	DOCK4 DSC2 RUNX1	4.16e-04	33	94	3	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k2_100
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_200	DOCK4 DSC2 MUC16 RUNX1 HMCN1	4.38e-04	143	94	5	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_200
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#3_top-relative-expression-ranked_100	DOCK4 DSC2 RUNX1	4.55e-04	34	94	3	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k3_100
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000	CD248 MUC16 ZC3H12B PTPRD HMCN1 NYNRIN CACNA1H	4.57e-04	310	94	7	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000
CoexpressionAtlas	dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_100	DOCK4 DSC2 RUNX1 ETNK2	5.07e-04	83	94	4	gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_100
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500	CD248 MUC16 DZIP1 NR4A1 NYNRIN	5.13e-04	148	94	5	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k4_500
CoexpressionAtlas	DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_1000	CBLL1 ARID1A AHDC1 FOXP4 PTPRD UBAP2L NYNRIN CACNA1H MGA	5.25e-04	524	94	9	gudmap_developingGonad_e12.5_testes_k1_1000
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_100	DOCK4 DSC2 MUC16 RUNX1	5.54e-04	85	94	4	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_100
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000	CD248 MUC16 ZC3H12B NR4A1 PTPRD HMCN1 NYNRIN KIAA1217 ETNK2 CACNA1H NOTCH2	5.80e-04	768	94	11	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200	MUC16 NR4A1 HMCN1 KIAA1217 ETNK2	5.96e-04	153	94	5	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_200
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#3_top-relative-expression-ranked_200	DOCK4 DSC2 RUNX1	6.33e-04	38	94	3	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k3_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_1000	ANO9 DSC2 SPINT1 CORO2A TMEM79 NR4A1 PTPRD PKP3 AUTS2 ASXL2 KDF1	6.60e-04	780	94	11	gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_1000	MAP1A CD248 MUC16 DZIP1 NR4A1 NYNRIN	6.96e-04	240	94	6	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k1_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#3_top-relative-expression-ranked_1000	KIAA1217 ETNK2 CACNA1H NOTCH2	7.17e-04	91	94	4	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k3_1000
CoexpressionAtlas	dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_100	DOCK4 DSC2 NR4A1 RUNX1	7.47e-04	92	94	4	gudmap_dev gonad_e11.5_F_GonMes_Sma_100
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000	MAP1A CD248 MUC16 DZIP1 PTPRD HMCN1 NYNRIN	7.49e-04	337	94	7	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_200	DOCK4 DSC2 CD248 MUC16 ETNK2	7.72e-04	162	94	5	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_200
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#2_top-relative-expression-ranked_200	CD248 MUC16 HMCN1	8.51e-04	42	94	3	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k2_200
CoexpressionAtlas	FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_100	DSC2 SPINT1 CECR2 KDF1	9.47e-04	98	94	4	Facebase_RNAseq_e9.5_Olfactory Placode_100
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	CBLL1 TCF7L2 MAP1A ZC3H12B MLLT10 LMTK3 ARID1A NCKAP5L FOXP4 KIAA1549L SETBP1 AUTS2 CACNA1H RERE TOX2	9.69e-04	1370	94	15	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_100	NRG1 SPINT1 CECR2 HESX1	9.83e-04	99	94	4	Facebase_RNAseq_e8.5_Floor Plate_100
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500	CD248 MUC16 HMCN1 NYNRIN KIAA1217 ETNK2 NOTCH2	1.03e-03	356	94	7	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000	CD248 MUC16 DZIP1 NR4A1 HMCN1 NYNRIN	1.16e-03	265	94	6	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500	CD248 MUC16 HMCN1 NYNRIN KIAA1217 ETNK2 NOTCH2	1.17e-03	364	94	7	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500
CoexpressionAtlas	dev gonad_e13.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_200	DOCK4 DSC2 RUNX1	1.18e-03	47	94	3	gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_k1_200
CoexpressionAtlas	gudmap_RNAseq_e11.5_Ureteric_bud_2500_K0	ANO9 DSC2 SPINT1 CORO2A TMEM79 NR4A1 PKP3 KIAA1217 KDF1 PLXNB1	1.20e-03	711	94	10	gudmap_RNAseq_e11.5_Ureteric_bud_2500_K0
CoexpressionAtlas	FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000	DSC2 SPINT1 CECR2 DACH1 RUNX1 KIAA1549L RTL3 PKP3 KIAA1217 KDF1 TOX2 PLXNB1	1.20e-03	973	94	12	Facebase_RNAseq_e9.5_Olfactory Placode_1000
CoexpressionAtlas	dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000	DOCK4 DSC2 CD248 MUC16 ZC3H12B NR4A1 RUNX1 HMCN1 KIAA1217 ETNK2 MERTK	1.31e-03	849	94	11	gudmap_dev gonad_e11.5_M_GonMes_Sma_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_500	DOCK4 DSC2 CD248 MUC16 NR4A1 RUNX1 HMCN1	1.33e-03	372	94	7	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500	CD248 MUC16 NR4A1 HMCN1 NYNRIN KIAA1217 ETNK2	1.35e-03	373	94	7	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000	NRG1 TCF7L2 DSC2 SPINT1 CECR2 RNF44 DACH1 MLLT10 HESX1 KIAA1549L PRRC2C TOX2	1.44e-03	994	94	12	Facebase_RNAseq_e8.5_Floor Plate_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_500	NRG1 TCF7L2 MAP1A SPINT1 CECR2 RNF44 HESX1 TOX2	1.47e-03	489	94	8	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_500
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK4 FLI1 DACH1 KIAA1671 PTPRD HMCN1 KIAA1217	2.07e-07	193	96	7	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	LV-09._Endothelium_I\|LV / Chamber and Cluster_Paper	DOCK4 FLI1 DACH1 KIAA1671 HMCN1 KIAA1217 ELK3	2.38e-07	197	96	7	f9731d4d636e51b94a96805eee6afe9aedc175e3
ToppCell	3'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DOCK4 FLI1 RBMS1 IFITM2 IFI16 HMCN1 ELK3	2.63e-07	200	96	7	cee07d9370656e1c428a7a9e9fbd175129901374
ToppCell	10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tfh\|GI_large-bowel / Manually curated celltypes from each tissue	AHDC1 AXIN2 PKP3 CACNA1H KDF1 TOX2	1.46e-06	163	96	6	4104d3b9748b39cb0744c9be76db21bdda566a0d
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3\|lymph-node_spleen / Manually curated celltypes from each tissue	DACH1 TNFSF11 PTPRD KIAA1217 CYP26C1 TOX2	2.95e-06	184	96	6	479e60f76c191253e23699c9dd7ef7efc08c59ad
ToppCell	COVID-19-Heart-EC_(POSTN)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FLI1 NRG1 IFITM2 KIAA1549L HMCN1 SETBP1	3.44e-06	189	96	6	7346c1112e2e155dbd71b6dbc80e680fd262a691
ToppCell	RA-10._Endothelium_II\|RA / Chamber and Cluster_Paper	FLI1 NRG1 KIAA1671 HMCN1 SETBP1 ELK3	3.44e-06	189	96	6	c81787a8c662db5d7814c583dd64562857629e81
ToppCell	E18.5-samps-Mesenchymal\|E18.5-samps / Age Group, Lineage, Cell class and subclass	TCF7L2 CD248 IFITM2 DZIP1 PTPRD NOTCH2	3.44e-06	189	96	6	0c18d3de4720759cf802eefb4d0ddde2a9246a1a
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DACH1 NR4A1 KIAA1549L HMCN1 SETBP1 TOX2	3.54e-06	190	96	6	f6c38d197fd9d69a4f97cb2e72cd4747984c1a86
ToppCell	COVID-19-Heart-EC_(POSTN)\|Heart / Disease (COVID-19 only), tissue and cell type	FLI1 NRG1 IFITM2 KIAA1549L HMCN1 SETBP1	3.76e-06	192	96	6	c0c34785a7bdf461722029b322e9184e3d9b3c26
ToppCell	LPS-IL1RA+antiTNF-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLI1 DACH1 KIAA1671 KIAA1217 ELK3 TOX2	3.76e-06	192	96	6	04f5a2e3dd6beff027b89d66eefdd92036e041af
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLI1 DACH1 KIAA1671 KIAA1217 ELK3 TOX2	3.76e-06	192	96	6	c07d7b40b2aa4eb27ac85801c014a656e2fd01dc
ToppCell	RV-10._Endothelium_II\|RV / Chamber and Cluster_Paper	DOCK4 FLI1 NRG1 KIAA1671 HMCN1 SETBP1	3.88e-06	193	96	6	01c2df9206f1527c578e808978e58196c35e72f5
ToppCell	LPS-antiTNF-Endothelial-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLI1 DACH1 KIAA1671 KIAA1217 ELK3 TOX2	3.88e-06	193	96	6	02f633b016ab19bfa65bfd0cf32f000549a62148
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLI1 DACH1 KIAA1671 HMCN1 KIAA1217 ELK3	3.88e-06	193	96	6	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	LPS-antiTNF-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLI1 DACH1 KIAA1671 KIAA1217 ELK3 TOX2	3.88e-06	193	96	6	5122b1ffba42de190061be34ecdc6176f84e56a3
ToppCell	RV-10._Endothelium_II\|World / Chamber and Cluster_Paper	DOCK4 FLI1 NRG1 KIAA1671 HMCN1 SETBP1	3.88e-06	193	96	6	2531266bc57339d4e2b22a88817008e32b8c1598
ToppCell	RV-09._Endothelium_I\|World / Chamber and Cluster_Paper	FLI1 DACH1 KIAA1671 HMCN1 KIAA1217 ELK3	3.88e-06	193	96	6	e3fa47e2c7cd8a5b69186711c57751f2296de8ae
ToppCell	RV-09._Endothelium_I\|RV / Chamber and Cluster_Paper	FLI1 DACH1 KIAA1671 HMCN1 KIAA1217 ELK3	3.99e-06	194	96	6	7b408096e717f2327c12aea35a8d5fc4621d3b06
ToppCell	LPS-IL1RA-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLI1 DACH1 KIAA1671 KIAA1217 ELK3 TOX2	3.99e-06	194	96	6	43f92b0533e26633dc94cce554045d641ef8fd76
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLI1 DACH1 KIAA1671 HMCN1 KIAA1217 TOX2	3.99e-06	194	96	6	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	LPS-IL1RA-Endothelial-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLI1 DACH1 KIAA1671 KIAA1217 ELK3 TOX2	3.99e-06	194	96	6	1d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell	LA-09._Endothelium_I\|World / Chamber and Cluster_Paper	FLI1 DACH1 KIAA1671 HMCN1 KIAA1217 ELK3	4.11e-06	195	96	6	fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	DSC2 MUC16 IFITM2 GRM6 PTPRD HMCN1	4.11e-06	195	96	6	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	DSC2 MUC16 IFITM2 GRM6 PTPRD HMCN1	4.11e-06	195	96	6	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	LV-09._Endothelium_I\|World / Chamber and Cluster_Paper	FLI1 DACH1 KIAA1671 HMCN1 KIAA1217 ELK3	4.11e-06	195	96	6	19e0a6c3eae1615aaa39767300acd937dfcb2a7f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK4 FLI1 IFI16 KIAA1549L ELK3 TOX2	4.11e-06	195	96	6	77e47d2e8b3eb7f7c9620369ccaf87581f923bdb
ToppCell	Endothelial\|World / Lineage, Cell type, age group and donor	FLI1 DACH1 KIAA1671 KIAA1217 ELK3 TOX2	4.24e-06	196	96	6	96c6d78482a130ce4e29f6629972a06d10d7530e
ToppCell	droplet-Mammary_Gland-nan-3m-Epithelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRG1 SPINT1 RUNX1 PKP3 TNS4 KDF1	4.36e-06	197	96	6	b1c6a15bf6c0645952a7247182dc71baf4736869
ToppCell	LA-09._Endothelium_I\|LA / Chamber and Cluster_Paper	FLI1 DACH1 KIAA1671 HMCN1 KIAA1217 ELK3	4.36e-06	197	96	6	ab6d1ab586a188597a39854ef980b8955ebcc645
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Vein\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FLI1 CORO2A IFI16 KIAA1549L HMCN1 ELK3	4.62e-06	199	96	6	cfb624c7728046fc7f3ef071f57e4d7b013f3fef
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial\|6m / Sample Type, Dataset, Time_group, and Cell type.	CD248 RBMS1 NR4A1 RUNX1 IFI16 ELK3	4.76e-06	200	96	6	2cc98abf11f5b58707de45a2282f03d47f00f035
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Vein\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FLI1 CORO2A IFI16 KIAA1549L HMCN1 ELK3	4.76e-06	200	96	6	7eb366b2c5394af7c77650bde6261e7dac67154e
ToppCell	Caecum-ILC\|Caecum / Region, Cell class and subclass	DACH1 TNFSF11 PTPRD CYP26C1 ERVV-1 TOX2	4.76e-06	200	96	6	a9a1f03b4f415da860fb52eaedb07f0743692c98
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26-Mesenchymal-BMP_responsible_cell\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	FLI1 RBMS1 NR4A1 RUNX1 IFI16 MERTK	4.76e-06	200	96	6	cd0d69f973ca3204b500d12031b403a1f4593431
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	FLI1 IFITM2 NR4A1 RUNX1 IFI16 MERTK	4.76e-06	200	96	6	fe22f7c97f4e37dfa7881d0f1d9245c1237d873b
ToppCell	Caecum-(3)_ILC-(30)_ILC\|Caecum / shred on region, Cell_type, and subtype	DACH1 TNFSF11 PTPRD CYP26C1 ERVV-1 TOX2	4.76e-06	200	96	6	ccd323997613b65f0189c0c66d76fbf273e18c03
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FLI1 DACH1 IFI16 KIAA1217 ELK3 TOX2	4.76e-06	200	96	6	a1fa6bae5a688faf488d6925cd3fad725dfa916b
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FLI1 DACH1 IFI16 KIAA1217 ELK3 TOX2	4.76e-06	200	96	6	89a6da2bdedc6b1ad0675c8753bf2b763a99af6a
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FLI1 DACH1 IFI16 KIAA1217 ELK3 TOX2	4.76e-06	200	96	6	b70b7adb7c187e6253c7f0bb4c1f09c85ef7142c
ToppCell	LPS_anti-TNF-Endothelial\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FLI1 DACH1 IFI16 KIAA1217 ELK3 TOX2	4.76e-06	200	96	6	1d105eeda5a2c51f9a4654ffc79b7e2348ad593b
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-BMP_responsible_cell\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	FLI1 IFITM2 NR4A1 RUNX1 IFI16 MERTK	4.76e-06	200	96	6	26251ed8c7fa7e87973d6f59bd398c88ad025395
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial-Proteoglycan-expressing_cell\|6m / Sample Type, Dataset, Time_group, and Cell type.	CD248 RBMS1 NR4A1 RUNX1 IFI16 ELK3	4.76e-06	200	96	6	0f7431f670f3a175377cefae3479403a881bb8fb
ToppCell	Caecum-ILC-ILC\|Caecum / Region, Cell class and subclass	DACH1 TNFSF11 PTPRD CYP26C1 ERVV-1 TOX2	4.76e-06	200	96	6	3ac18c3ef335cb83d6a826f6c7519a5e7804929d
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FLI1 DACH1 IFI16 KIAA1217 ELK3 TOX2	4.76e-06	200	96	6	58a7ece7dfdf6c46f2a50cbcb580574dec14c748
ToppCell	LPS_IL1RA_TNF-Endothelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FLI1 DACH1 IFI16 KIAA1217 ELK3 TOX2	4.76e-06	200	96	6	d01cec331be3b03cef80e9536fc531285bcf00f6
ToppCell	LPS_anti-TNF-Endothelial-Endothelial\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FLI1 DACH1 IFI16 KIAA1217 ELK3 TOX2	4.76e-06	200	96	6	60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af
ToppCell	Caecum-(3)_ILC\|Caecum / shred on region, Cell_type, and subtype	DACH1 TNFSF11 PTPRD CYP26C1 ERVV-1 TOX2	4.76e-06	200	96	6	6857863b3200162c250123688af2cba681afcb35
ToppCell	metastatic_Brain-Myeloid_cells-Pleural_Mac\|Myeloid_cells / Location, Cell class and cell subclass	IFITM2 CD1E LINC02908 SETBP1 TNS4	1.51e-05	144	96	5	6f1158c85e1d50ef6f2c67abdb2dc855a9786b9a
ToppCell	3'_v3-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3\|bone_marrow / Manually curated celltypes from each tissue	MYRFL TNFSF11 PTPRD NYNRIN TOX2	1.79e-05	149	96	5	d7f1069f70f3cad6d3700ee2041ed1d4cb7c49ab
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_C\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	TMEM79 TNFSF11 LINC02908 ETNK2	3.00e-05	82	96	4	32ab4ee9c39b976b1ddf68864a256a0e942327ff
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	VWA7 ARID1A UBAP2L MGA PLXNB1	3.00e-05	166	96	5	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3\|GI_small-bowel / Manually curated celltypes from each tissue	MYRFL TNFSF11 PTPRD CYP26C1 TOX2	3.00e-05	166	96	5	773673a5d0430640439845b264740bfbbdad0cb2
ToppCell	ILEUM-non-inflamed-(3)_MNP-(3)_pDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	MAP1A DACH1 NEUROD1 TOX2 PLXNB1	3.09e-05	167	96	5	8ddf9da71a7c4ed53588435db826563a24cee616
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like\|GI_small-bowel / Manually curated celltypes from each tissue	MYRFL TNFSF11 PTPRD CYP26C1 TOX2	3.09e-05	167	96	5	3ae46c6363da76c8e1f5579e6027bf88ed637a44
ToppCell	facs-Heart-LA-24m-Lymphocytic-T_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CORO2A TNFSF11 PKP3 TNS4 BSN	3.09e-05	167	96	5	ed75e9715c795e1cc8e58c8a90ed392569404147
ToppCell	facs-Heart-LA-24m-Lymphocytic-T_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CORO2A TNFSF11 PKP3 TNS4 BSN	3.09e-05	167	96	5	f34b34f531b9ed548ed5701305898092c41b9a9b
ToppCell	15-Airway-Epithelial-Submucosal_gland_basal\|Airway / Age, Tissue, Lineage and Cell class	SPINT1 KIAA1549L PKP3 KIAA1217 KDF1	3.36e-05	170	96	5	61f8dd5e27df1b8d01ccfd0d25247b34aa8d182c
ToppCell	wk_08-11-Epithelial-Proximal_epithelial-basal_late\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	CORO2A LMTK3 CFAP77 PKP3 OTOG	3.36e-05	170	96	5	83320d37f0fc74e492cfe3de18f5c499eaa9fd3e
ToppCell	343B-Fibroblasts-Fibroblast-B_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	DACH1 ZC3H12B HMCN1 NYNRIN CABIN1	3.55e-05	172	96	5	c6bc78fd63c9479a84ec0552b55c89750cad0fa5
ToppCell	343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	DACH1 ZC3H12B HMCN1 NYNRIN CABIN1	3.55e-05	172	96	5	bfb87a281a9cf6ad45b310bf8104fc0ab382b549
ToppCell	facs-Marrow-B-cells-18m-Lymphocytic-early_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF7L2 CECR2 GRIA2 ZC3H12B KIAA1671	3.76e-05	174	96	5	268be5e7d2a18b866770b7cdb966c3958c7e6534
ToppCell	facs-Marrow-B-cells-18m-Lymphocytic-early_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF7L2 CECR2 GRIA2 ZC3H12B KIAA1671	3.76e-05	174	96	5	4cdf2eedc28d88d18241ee390092426fdf849e79
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_cell-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	FRS3 LMTK3 NSUN2 ZNF500 TOX2	3.86e-05	175	96	5	69ed3c7c45df6bef70f5f2ff003531160bf3b32b
ToppCell	facs-Trachea-nan-18m\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSC2 SPINT1 TMEM79 PKP3 KDF1	4.07e-05	177	96	5	fc30276903bcb1e95ae76f6cee3d17408158941a
ToppCell	facs-Trachea-18m\|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DSC2 SPINT1 TMEM79 PKP3 KDF1	4.07e-05	177	96	5	68c9a8a82c956cbfdf03b44984c97f978aaaf80f
ToppCell	Control-Myeloid-pDC\|World / Disease state, Lineage and Cell class	MAP1A DACH1 SETBP1 AUTS2 TOX2	4.19e-05	178	96	5	20ef63d925e67ddd5955832312ca8574a6f838a4
ToppCell	droplet-Fat-Bat-18m-Endothelial-endothelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRS3 NCKAP5L ETNK2 MERTK PLXNB1	4.30e-05	179	96	5	e6224864eb76a2e9c1fc0c61513d9e936bb5c72c
ToppCell	droplet-Fat-Bat-18m-Endothelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRS3 NCKAP5L ETNK2 MERTK PLXNB1	4.30e-05	179	96	5	9863ab3ceb160a4b1d9790033a4ac48845863d65
ToppCell	droplet-Fat-Bat-18m-Endothelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRS3 NCKAP5L ETNK2 MERTK PLXNB1	4.30e-05	179	96	5	dfe110add7228cd834b35916cbcc849769a01bb9
ToppCell	IPF-Lymphoid-ILC_B\|IPF / Disease state, Lineage and Cell class	DACH1 IFITM2 TNFSF11 AUTS2 TOX2	4.41e-05	180	96	5	b2fde7cd140a3ede8cac2d06f1f72eb438def82e
ToppCell	CV-Severe-4\|Severe / Virus stimulation, Condition and Cluster	CNOT10 NR4A1 TNFSF11 KIAA1217 TOX2	4.41e-05	180	96	5	cf84a01e6a33e5d27ad7be1d9069a0370b5116d1
ToppCell	15-Airway-Epithelial-Submucosal_gland\|Airway / Age, Tissue, Lineage and Cell class	ANO9 DSC2 SPINT1 PKP3 KDF1	4.41e-05	180	96	5	283bb0d58811947bfda4e286b9ec87d869c8e29e
ToppCell	CV-Severe-4\|CV / Virus stimulation, Condition and Cluster	CNOT10 TNFSF11 UBAP2L KIAA1217 TOX2	4.65e-05	182	96	5	c19bbc43d97c426aec37414f46f667a19b62a257
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IFITM2 NR4A1 HESX1 CD1E ELK3	4.77e-05	183	96	5	bd78e5c2670e67b4363078e3ca5a5b7081d24b7e
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IFITM2 NR4A1 HESX1 CD1E ELK3	4.77e-05	183	96	5	d1bf3abf42eb9d7facf775becf1338d1faadd647
ToppCell	Control-Endothelial-Endothelial-Activated_Alv_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK4 FLI1 DACH1 KIAA1671 KIAA1217	4.77e-05	183	96	5	e81c142770f44fd902b0631bc360c5b5339d4c75
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like\|lymph-node_spleen / Manually curated celltypes from each tissue	DACH1 TNFSF11 KIAA1217 CYP26C1 TOX2	4.90e-05	184	96	5	d97471a4fe17cba6880ccf1a04cc00c741558124
ToppCell	Mesenchymal_cells-Smooth_muscle\|Mesenchymal_cells / Lineage and Cell class	NUP210L SLC6A17 ETNK2 CACNA1H TOX2	4.90e-05	184	96	5	83987abaedc26e6da477bc70d65e10b1ab1aea60
ToppCell	Control-Lymphoid-ILC_A\|Lymphoid / Disease state, Lineage and Cell class	DACH1 IFITM2 AUTS2 RERE TOX2	5.03e-05	185	96	5	520795866d44def5be3910ce8e728045c716a24d
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DACH1 NR4A1 KIAA1549L HMCN1 TOX2	5.03e-05	185	96	5	a7ae76058b2082020cadec49d63b9f4e24d21734
ToppCell	Control-Endothelial-Endothelial-Alv_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK4 FLI1 DACH1 KIAA1671 KIAA1217	5.29e-05	187	96	5	ea9d34bcd3bd1f36745846309ede349773de501a
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TCF7L2 CECR2 MERTK PLXNB1 NOTCH2	5.29e-05	187	96	5	dd1d91f101b837bba513f77defa6e6902b2c0570
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TCF7L2 CECR2 MERTK PLXNB1 NOTCH2	5.29e-05	187	96	5	4d2115a05ec36dd179ca1d4a525f2d4501aea557
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TCF7L2 CECR2 MERTK PLXNB1 NOTCH2	5.29e-05	187	96	5	ae90c263f80c36a410150d499e268d198944a3d9
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175\|Adult / Lineage, Cell type, age group and donor	FLI1 DACH1 NR4A1 KIAA1217 TOX2	5.29e-05	187	96	5	f3548817f2fded5978137bb252cb628ac199e4f6
ToppCell	(6)_ILC\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	DACH1 TNFSF11 NYNRIN CYP26C1 TOX2	5.43e-05	188	96	5	de7cb273899d0e0748c85f45c6b5e7f0642ab057
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLI1 TCF7L2 NUP210L IFITM2 NR4A1	5.43e-05	188	96	5	5e13725136114e42d3b59647cf25e0f3c53abb54
ToppCell	(6)_ILC\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	DACH1 TNFSF11 NYNRIN CYP26C1 TOX2	5.43e-05	188	96	5	f4734d5b703678670ece204a0519cf015e180a6e
ToppCell	3'-Adult-Distal_Rectal-Endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DOCK4 RBMS1 IFITM2 IFI16 ELK3	5.56e-05	189	96	5	0c612ff5f882f2d8ec744a347780bbbe7cc471bd
ToppCell	Endothelial-endothelial_cell_of_artery\|World / Lineage, Cell type, age group and donor	DACH1 NR4A1 KIAA1549L HMCN1 TOX2	5.56e-05	189	96	5	fdd89c71113ac99b7c800c6def8888e512ff1128
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DACH1 KIAA1671 HMCN1 MERTK TOX2	5.56e-05	189	96	5	c45734970036e6d28d5e3fe7c9458fae38a3f624
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK4 FLI1 KIAA1549L ELK3 TOX2	5.56e-05	189	96	5	12b6f1c3bf526b90e112374bf937701f645c5780
ToppCell	RA-10._Endothelium_II\|World / Chamber and Cluster_Paper	FLI1 NRG1 KIAA1671 HMCN1 SETBP1	5.56e-05	189	96	5	75c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCell	facs-Skin-Skin_Anagen-18m-Epithelial-outer_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF7L2 RUNX1 VWA7 HMCN1 PIP5KL1	5.56e-05	189	96	5	d00410010283dc6191ce9857d6c7952678fed588
ToppCell	Control-Endothelial-Endothelial-Alv_Gen_Intermediate\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK4 FLI1 DACH1 KIAA1671 PTPRD	5.56e-05	189	96	5	5d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1
ToppCell	3'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DOCK4 RBMS1 IFITM2 IFI16 ELK3	5.56e-05	189	96	5	bc8949bd4f425ed36e2c05e653c94cb1593c5bee
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Epithelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLI1 TCF7L2 NR4A1 RUNX1 VWA7	5.70e-05	190	96	5	92456f6f7eced6e4c4371f495254a65d061c8d0b
ToppCell	COVID-19-kidney-AQP1+SLC14A1+EC\|kidney / Disease (COVID-19 only), tissue and cell type	DOCK4 FLI1 IFI16 KIAA1549L TOX2	5.70e-05	190	96	5	1519f34d31fe0817184c5865a0bc9f0cb479b1a4
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DOCK4 DACH1 KIAA1671 KIAA1217 TOX2	5.70e-05	190	96	5	0e9847d7f49b2236b8a191e1a7df37556351ba9e
Drug	Buspirone hydrochloride [33386-08-2]; Down 200; 9.4uM; PC3; HT_HG-U133A	MAP1A DZIP1 RUNX1 AHDC1 NEUROD1 PKP3 ZNF500 MERTK NOTCH2	1.15e-07	199	92	9	6743_DN
Drug	Mephenesin [59-47-2]; Up 200; 22uM; HL60; HT_HG-U133A	WASF3 FRS3 NR4A1 RUNX1 TNFSF11 SETBP1 PLXNB1 NOTCH2	1.42e-06	198	92	8	2342_UP
Drug	Picotamide monohydrate [80530-63-8]; Up 200; 10.2uM; PC3; HT_HG-U133A	FLI1 DSC2 CORO2A IFI16 AHDC1 TRIM33 NYNRIN CABIN1	1.53e-06	200	92	8	2070_UP
Drug	N,N-dimethylaniline	TCF7L2 AXIN2 PYGO2	2.21e-06	7	92	3	ctd:C015157
Drug	wortmannin from Penicillium funiculosum; Up 200; 0.01uM; PC3; HT_HG-U133A	DSC2 RNF44 DZIP1 RUNX1 TNS4 RERE CABIN1	1.26e-05	191	92	7	1243_UP
Drug	Papaverine hydrochloride [61-25-6]; Up 200; 10.6uM; PC3; HT_HG-U133A	FLI1 DACH1 DZIP1 NR4A1 NEUROD1 AUTS2 MERTK	1.49e-05	196	92	7	5769_UP
Drug	Nifenazone [2139-47-1]; Up 200; 13uM; PC3; HT_HG-U133A	FLI1 TCF7L2 FRS3 RUNX1 PKP3 TNS4 NOTCH2	1.54e-05	197	92	7	2122_UP
Drug	Baclofen (R,S) [1134-47-0]; Down 200; 18.8uM; MCF7; HT_HG-U133A	TCF7L2 DSC2 CORO2A ATG13 RUNX1 PLXNB1 NOTCH2	1.59e-05	198	92	7	5414_DN
Drug	rhodium complex	DACH1 IFITM2 MERTK	1.77e-05	13	92	3	CID010056476
Drug	octylmethoxycinnamate	NRG1 CYP11B2 GRIA2 CACNA1H BSN NOTCH2	2.15e-05	139	92	6	ctd:C118580
Drug	AC1NUV1C	DSC2 GRIA2 HESX1 RERE	6.28e-05	53	92	4	CID005494394
Drug	Fe-mo-s Cluster	CD248 RBMS1 GRIA2	9.30e-05	22	92	3	CID000445682
Drug	3,5-dihydroxyphenylglycine	GRIA2 NR4A1 GRM6 BSN	1.02e-04	60	92	4	CID000108001
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	CBLL1 TCF7L2 ARID1A TRIM33 TAF4 MGA	1.03e-04	184	92	6	2321_DN
Drug	YM90K	GRIA2 GRM6 CABIN1	1.07e-04	23	92	3	CID005486547
Drug	Ethynodiol diacetate [297-76-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A	PIGN DOCK4 FLI1 TCF7L2 CORO2A MLLT10	1.34e-04	193	92	6	5024_DN
Drug	trichostatin A; Down 200; 0.1uM; ssMCF7; HG-U133A	ATG13 MLLT10 NR4A1 RUNX1 ARID1A TRIM33	1.34e-04	193	92	6	413_DN
Drug	Napelline [5008-52-6]; Down 200; 11.2uM; MCF7; HT_HG-U133A	FLI1 ARID1A TRIM33 AUTS2 RERE MERTK	1.38e-04	194	92	6	6084_DN
Drug	(-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; HL60; HT_HG-U133A	TCF7L2 MAP1A WASF3 FRS3 MLLT10 RUNX1	1.38e-04	194	92	6	3015_DN
Drug	Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; PC3; HT_HG-U133A	TCF7L2 MLLT10 ARID1A KIAA1549L SETBP1 LRP6	1.38e-04	194	92	6	4284_DN
Drug	Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A	PIGN TCF7L2 DACH1 PRRC2C PKP3 LRP6	1.38e-04	194	92	6	4361_DN
Drug	S(-)Eticlopride hydrochloride [97612-24-3]; Down 200; 10.6uM; MCF7; HT_HG-U133A	FLI1 DSC2 NR4A1 NYNRIN LRP6 RERE	1.41e-04	195	92	6	3393_DN
Drug	Bumetanide [28395-03-1]; Down 200; 11uM; HL60; HT_HG-U133A	SPINT1 WASF3 DACH1 NR4A1 AHDC1 LRP6	1.41e-04	195	92	6	2409_DN
Drug	Gemfibrozil [25812-30-0]; Up 200; 16uM; PC3; HT_HG-U133A	TCF7L2 WASF3 NR4A1 RUNX1 PLXNB1 NOTCH2	1.41e-04	195	92	6	2113_UP
Drug	Atovaquone [95233-18-4]; Down 200; 11uM; PC3; HT_HG-U133A	ATG13 NR4A1 TRIM33 PKP3 ZNF500 RERE	1.41e-04	195	92	6	4201_DN
Drug	Pyridoxine hydrochloride [58-56-0]; Up 200; 19.4uM; PC3; HT_HG-U133A	CORO2A FRS3 RUNX1 ARID1A UBAP2L NOTCH2	1.41e-04	195	92	6	5813_UP
Drug	Antipyrine [60-80-0]; Down 200; 21.2uM; PC3; HT_HG-U133A	NRG1 RUNX1 PKP3 LRP6 RERE PLXNB1	1.41e-04	195	92	6	4251_DN
Drug	Flumethasone [2135-17-3]; Up 200; 9.8uM; PC3; HT_HG-U133A	FLI1 RUNX1 PKP3 ELK3 TNS4 RERE	1.41e-04	195	92	6	4272_UP
Drug	Droperidol [548-73-2]; Down 200; 10.6uM; HL60; HT_HG-U133A	SPINT1 DACH1 ARID1A UBAP2L PRRC2C ZNF500	1.41e-04	195	92	6	1290_DN
Drug	Guanethidine sulfate [60-02-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A	DOCK4 RUNX1 NEUROD1 NYNRIN CACNA1H MERTK	1.45e-04	196	92	6	3171_UP
Drug	rosiglitazone; Down 200; 10uM; HL60; HT_HG-U133A	TCF7L2 ATG13 WASF3 DACH1 DZIP1 CABIN1	1.45e-04	196	92	6	1174_DN
Drug	Carbimazole [22232-54-8]; Down 200; 21.4uM; HL60; HT_HG-U133A	TCF7L2 DZIP1 RUNX1 ARID1A LRP6 NOTCH2	1.45e-04	196	92	6	2437_DN
Drug	Metergoline [17692-51-2]; Down 200; 10uM; HL60; HG-U133A	FLI1 MAP1A MLLT10 UBAP2L ELK3 CABIN1	1.45e-04	196	92	6	1606_DN
Drug	Benzamil hydrochloride [2898-76-2]; Up 200; 11.2uM; PC3; HT_HG-U133A	DACH1 NR4A1 RUNX1 GRM6 RERE PLXNB1	1.45e-04	196	92	6	3738_UP
Drug	Phenformin hydrochloride [834-28-6]; Up 200; 16.6uM; PC3; HT_HG-U133A	FLI1 DZIP1 RUNX1 CD1E PKP3 MERTK	1.45e-04	196	92	6	4283_UP
Drug	Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; MCF7; HT_HG-U133A	NR4A1 NYNRIN ETNK2 LRP6 CACNA1H MERTK	1.45e-04	196	92	6	2291_DN
Drug	Graveoline [485-61-0]; Down 200; 14.4uM; PC3; HT_HG-U133A	FLI1 RUNX1 ELK3 RERE CABIN1 PLXNB1	1.45e-04	196	92	6	4276_DN
Drug	Lomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; PC3; HT_HG-U133A	FLI1 CD248 RUNX1 PKP3 NYNRIN MERTK	1.45e-04	196	92	6	4281_UP
Drug	Terconazole [67915-31-5]; Down 200; 7.6uM; MCF7; HT_HG-U133A	TCF7L2 RUNX1 CD1E NEUROD1 ETNK2 CABIN1	1.45e-04	196	92	6	4407_DN
Drug	Pizotifen malate [5189-11-7]; Down 200; 9.4uM; PC3; HT_HG-U133A	FLI1 FRS3 DZIP1 ETNK2 LRP6 ELK3	1.45e-04	196	92	6	5072_DN
Drug	Ioversol [87771-40-2]; Down 200; 5uM; HL60; HT_HG-U133A	TCF7L2 FRS3 MLLT10 RUNX1 ARID1A NOTCH2	1.50e-04	197	92	6	3026_DN
Drug	Metronidazole [443-48-1]; Up 200; 23.4uM; MCF7; HT_HG-U133A	TCF7L2 MLLT10 AHDC1 NYNRIN ETNK2 LRP6	1.50e-04	197	92	6	1503_UP
Drug	Trimipramine maleate salt [521-78-8]; Down 200; 9.8uM; HL60; HT_HG-U133A	NRG1 MAP1A IL37 WASF3 FRS3 MLLT10	1.50e-04	197	92	6	3004_DN
Drug	Parbendazole [14255-87-9]; Down 200; 16.2uM; PC3; HT_HG-U133A	DSC2 MAP1A DZIP1 MLLT10 RUNX1 MERTK	1.50e-04	197	92	6	4535_DN
Drug	Alclometasone dipropionate [667634-13-2]; Down 200; 7.6uM; PC3; HT_HG-U133A	FLI1 CORO2A FRS3 NR4A1 IFI16 NOTCH2	1.50e-04	197	92	6	5752_DN
Drug	Phthalylsulfathiazole [85-73-4]; Up 200; 10uM; MCF7; HT_HG-U133A	MAP1A RUNX1 SETBP1 CACNA1H ELK3 CABIN1	1.50e-04	197	92	6	5249_UP
Drug	Betonicine [515-25-3]; Down 200; 25.2uM; MCF7; HT_HG-U133A	FLI1 DACH1 ARID1A AUTS2 CACNA1H MERTK	1.50e-04	197	92	6	4767_DN
Drug	Pentolinium bitartrate [52-62-0]; Down 200; 7.4uM; MCF7; HT_HG-U133A	FLI1 TCF7L2 DSC2 DACH1 RUNX1 NEUROD1	1.50e-04	197	92	6	4699_DN
Drug	Gossypol [303-45-7]; Down 200; 7.8uM; MCF7; HT_HG-U133A	DACH1 RUNX1 ARID1A UBAP2L ETNK2 RERE	1.54e-04	198	92	6	4762_DN
Drug	Ganciclovir [82410-32-0]; Up 200; 15.6uM; PC3; HT_HG-U133A	FRS3 DZIP1 IFI16 HESX1 ETNK2 MERTK	1.54e-04	198	92	6	6289_UP
Drug	Ampicillin trihydrate [7177-48-2]; Up 200; 10uM; MCF7; HT_HG-U133A	MAP1A RUNX1 ARID1A NEUROD1 SETBP1 RERE	1.54e-04	198	92	6	5408_UP
Drug	Benfotiamine [22457-89-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A	DACH1 UBAP2L AUTS2 LRP6 CABIN1 NOTCH2	1.54e-04	198	92	6	6032_DN
Drug	Gabazine [105538-73-6]; Down 200; 10.8uM; HL60; HT_HG-U133A	TCF7L2 ATG13 DACH1 RUNX1 LRP6 NOTCH2	1.54e-04	198	92	6	1316_DN
Drug	novobiocin sodium, USP; Up 200; 100uM; PC3; HG-U133A	FLI1 NRG1 FRS3 RUNX1 AHDC1 LRP6	1.54e-04	198	92	6	435_UP
Drug	clozapine; Up 200; 10uM; HL60; HT_HG-U133A	FLI1 TCF7L2 MLLT10 NR4A1 RUNX1 RERE	1.54e-04	198	92	6	1170_UP
Drug	Nimodipine [66085-59-4]; Up 200; 9.6uM; PC3; HT_HG-U133A	FLI1 ATG13 MLLT10 ARID1A GRM6 ETNK2	1.54e-04	198	92	6	6320_UP
Drug	Corynanthine hydrochloride [66634-44-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A	PIGN RUNX1 SETBP1 CACNA1H RERE CABIN1	1.54e-04	198	92	6	4811_UP
Drug	Iproniazide phosphate [305-33-9]; Up 200; 14.4uM; PC3; HT_HG-U133A	PRRC2C PKP3 ELK3 RERE MERTK NOTCH2	1.54e-04	198	92	6	2125_UP
Drug	Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; PC3; HT_HG-U133A	MAP1A MLLT10 RUNX1 AHDC1 PKP3 LRP6	1.54e-04	198	92	6	7366_DN
Drug	Nitrendipine [39562-70-4]; Down 200; 11uM; MCF7; HT_HG-U133A	DSC2 DACH1 AHDC1 ETNK2 MERTK PLXNB1	1.54e-04	198	92	6	5405_DN
Drug	CP-645525-01 [287190-82-3]; Up 200; 10uM; MCF7; HT_HG-U133A	PIGN TCF7L2 ATG13 NR4A1 NYNRIN CACNA1H	1.54e-04	198	92	6	7515_UP
Drug	Naphazoline hydrochloride [550-99-2]; Up 200; 16.2uM; PC3; HT_HG-U133A	FLI1 NR4A1 RUNX1 ARID1A CD1E CABIN1	1.54e-04	198	92	6	6604_UP
Drug	troglitazone; Down 200; 10uM; HL60; HG-U133A	TCF7L2 CEBPE MLLT10 NR4A1 KIAA1549L MAGEC1	1.58e-04	199	92	6	370_DN
Drug	Paromomycin sulfate [1263-89-4]; Down 200; 5.6uM; HL60; HT_HG-U133A	NRG1 TCF7L2 MAP1A IL37 RUNX1 LRP6	1.58e-04	199	92	6	3017_DN
Drug	Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A	DOCK4 FLI1 RUNX1 ARID1A LRP6 RERE	1.58e-04	199	92	6	4765_DN
Drug	Enilconazole [35554-44-0]; Down 200; 13.4uM; MCF7; HT_HG-U133A	SPINT1 MLLT10 AHDC1 RERE CABIN1 NOTCH2	1.58e-04	199	92	6	5538_DN
Drug	Sulfathiazole [72-14-0]; Up 200; 15.6uM; MCF7; HT_HG-U133A	FLI1 ATG13 NR4A1 NYNRIN LRP6 CABIN1	1.58e-04	199	92	6	1463_UP
Drug	Levocabastine hydrochloride [79547-78-7]; Up 200; 8.8uM; PC3; HT_HG-U133A	MLLT10 IFI16 PKP3 NYNRIN TAF4 CABIN1	1.58e-04	199	92	6	7249_UP
Drug	Tolazoline hydrochloride [59-97-2]; Up 200; 20.4uM; MCF7; HT_HG-U133A	FLI1 DSC2 RUNX1 NYNRIN AUTS2 ELK3	1.58e-04	199	92	6	1500_UP
Drug	Suloctidil [54063-56-8]; Down 200; 11.8uM; PC3; HT_HG-U133A	FLI1 FRS3 NR4A1 ETNK2 PLXNB1 NOTCH2	1.58e-04	199	92	6	6675_DN
Drug	(cis-) Nanophine [5072-45-7]; Down 200; 26.8uM; PC3; HT_HG-U133A	DSC2 MLLT10 UBAP2L SETBP1 RERE PLXNB1	1.58e-04	199	92	6	4543_DN
Drug	AC1NBNWS	ELK3 NOTCH2	1.60e-04	5	92	2	CID004470974
Drug	enzacamene	NRG1 GRIA2 CACNA1H BSN NOTCH2	1.79e-04	129	92	5	ctd:C038939
Drug	Dichlorodiphenyl Dichloroethylene	NRG1 GRIA2 NR4A1 RUNX1 MERTK BSN NOTCH2	2.25e-04	302	92	7	ctd:D003633
Drug	AC1NB8R3	FLI1 CYP11B2 RUNX1 GRM6 AUTS2 TAF4	2.28e-04	213	92	6	CID004489307
Drug	Androgen Antagonists	NRG1 GRIA2 BSN NOTCH2	2.44e-04	75	92	4	ctd:D000726
Disease	C-reactive protein measurement	DOCK4 TCF7L2 MAP1A CD248 IL37 NUP210L TMEM79 MLLT10 IFI16 TNFSF11 NYNRIN CYP26C1 RERE TAF4 MERTK BSN KDF1	2.79e-07	1206	95	17	EFO_0004458
Disease	basophil measurement	FLI1 CEBPE RUNX1 RERE	4.28e-05	60	95	4	EFO_0803539
Disease	neuroticism measurement, cognitive function measurement	TCF7L2 CD248 NUP210L RBMS1 MLLT10 ARID1A KIAA1217 AUTS2 RERE	8.97e-05	566	95	9	EFO_0007660, EFO_0008354
Disease	primary hyperaldosteronism (is_implicated_in)	CYP11B2 CACNA1H	1.02e-04	5	95	2	DOID:446 (is_implicated_in)
Disease	neutrophil count	CEBPE IL37 NUP210L RBMS1 SLC6A17 IFITM2 VWA7 ARID1A IFI16 TRIM33 CD1E RERE TOX2 NOTCH2	1.34e-04	1382	95	14	EFO_0004833
Disease	self rated health	TCF7L2 SEC24C BSN	1.36e-04	31	95	3	EFO_0004778
Disease	Glycosuria	TCF7L2 NEUROD1	2.13e-04	7	95	2	HP_0003076
Disease	endometrial adenocarcinoma (is_implicated_in)	ARID1A AXIN2	2.13e-04	7	95	2	DOID:2870 (is_implicated_in)
Disease	Burkitt Lymphoma	RUNX1 ARID1A AUTS2	2.14e-04	36	95	3	C0006413
Disease	Leukemia, Myelocytic, Acute	MLLT10 RUNX1 SETBP1 ASXL2 NOTCH2	2.47e-04	173	95	5	C0023467
Disease	urinary albumin to creatinine ratio	TCF7L2 MLLT10 PRRC2C AUTS2 MGA	2.90e-04	179	95	5	EFO_0007778
Disease	monocyte count	FLI1 TCF7L2 CEBPE CECR2 IFITM2 MLLT10 RUNX1 VWA7 AHDC1 MYLK2 CD1E PIP5KL1 CABIN1	3.12e-04	1320	95	13	EFO_0005091
Disease	occupational attainment	TCF7L2 CD248 NPIPB6	3.39e-04	42	95	3	EFO_0020977
Disease	QRS duration	NRG1 CD1E PTPRD HMCN1 SETBP1 NOTCH2	4.13e-04	298	95	6	EFO_0005055
Disease	Colorectal Carcinoma	TCF7L2 CD248 ARID1A AXIN2 PTPRD CFAP77 SETBP1 TNS4 KDF1	4.41e-04	702	95	9	C0009402
Disease	endometrial carcinoma, endometriosis	AXIN2 PTPRD	5.54e-04	11	95	2	EFO_0001065, EFO_1001512
Disease	monocyte percentage of leukocytes	FLI1 TCF7L2 CEBPE RBMS1 CECR2 IFITM2 RUNX1 ARID1A RERE	5.90e-04	731	95	9	EFO_0007989
Disease	Ischemic stroke	NRG1 TCF7L2 FOXP4 NYNRIN SETBP1 AUTS2	6.41e-04	324	95	6	HP_0002140
Disease	Oligodontia	AXIN2 LRP6	6.63e-04	12	95	2	C4082304
Disease	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	RUNX1 MGA	6.63e-04	12	95	2	C0023485
Disease	monoclonal gammopathy	PTPRD SETBP1 AUTS2	6.74e-04	53	95	3	EFO_0000203
Disease	brain volume measurement	TCF7L2 NUP210L DACH1 MLLT10 MYLK2 NPIPB8 AUTS2 ASXL2	6.81e-04	595	95	8	EFO_0006930
Disease	uric acid measurement	PIGN NRG1 TCF7L2 RBMS1 DACH1 ARID1A SETBP1 ASXL2	8.01e-04	610	95	8	EFO_0004761
Disease	testosterone measurement	DOCK4 SPEM3 MAP1A CYP11B2 CECR2 DACH1 ARID1A HMCN1 NYNRIN CYP26C1 AUTS2 TAF4	8.03e-04	1275	95	12	EFO_0004908
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Positive	NRG1 TCF7L2 WASF3 RERE	8.64e-04	131	95	4	C4704862
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Negative	NRG1 TCF7L2 WASF3 RERE	8.64e-04	131	95	4	C4552091
Disease	Juvenile arthritis	NRG1 TCF7L2 WASF3 RERE	8.64e-04	131	95	4	C3495559
Disease	Juvenile psoriatic arthritis	NRG1 TCF7L2 WASF3 RERE	8.64e-04	131	95	4	C3714758
Disease	Hypodontia	AXIN2 LRP6	9.10e-04	14	95	2	C0020608
Disease	Juvenile-Onset Still Disease	NRG1 TCF7L2 WASF3 RERE	9.67e-04	135	95	4	C0087031
Disease	Precursor Cell Lymphoblastic Leukemia Lymphoma	CEBPE RUNX1 NOTCH2	1.02e-03	61	95	3	C1961102
Disease	chenodeoxycholate measurement	TCF7L2 HMCN1	1.05e-03	15	95	2	EFO_0010471
Disease	B-cell acute lymphoblastic leukemia	CEBPE ELK3	1.05e-03	15	95	2	EFO_0000094
Disease	alopecia	TCF7L2 ZC3H12B RUNX1 SETBP1 AUTS2	1.11e-03	241	95	5	MONDO_0004907
Disease	T-Cell Lymphoma	ARID1A MGA	1.20e-03	16	95	2	C0079772
Disease	Acute myeloid leukemia	MLLT10 RUNX1	1.35e-03	17	95	2	cv:C0023467
Disease	LEUKEMIA, ACUTE MYELOID	MLLT10 RUNX1	1.35e-03	17	95	2	601626
Disease	creatinine measurement	NRG1 TCF7L2 DACH1 ARID1A PRRC2C SETBP1 CYP26C1 ASXL2 TAF4 BSN	1.38e-03	995	95	10	EFO_0004518
Disease	lymphocyte percentage of leukocytes	FLI1 RBMS1 CECR2 IFITM2 ARID1A IFI16 LINC02908 RERE	1.39e-03	665	95	8	EFO_0007993
Disease	gait measurement	TCF7L2 MLLT10 PTPRD AUTS2	1.43e-03	150	95	4	EFO_0007680
Disease	p-tau measurement	NRG1 PTPRD AUTS2	1.64e-03	72	95	3	EFO_0004763
Disease	unipolar depression, bipolar disorder	TCF7L2 WASF3 SETBP1 RERE	1.65e-03	156	95	4	EFO_0003761, MONDO_0004985
Disease	Juvenile Myelomonocytic Leukemia	RUNX1 SETBP1	1.69e-03	19	95	2	C0349639
Disease	intrahepatic cholangiocarcinoma (is_marker_for)	RUNX1 ARID1A	1.69e-03	19	95	2	DOID:4928 (is_marker_for)
Disease	Left Ventricle Remodeling	TCF7L2 AXIN2	2.07e-03	21	95	2	C0600520
Disease	Ventricular Remodeling	TCF7L2 AXIN2	2.07e-03	21	95	2	C0600519
Disease	Precursor B-cell lymphoblastic leukemia	RUNX1 AUTS2	2.07e-03	21	95	2	C1292769
Disease	Anophthalmia-microphthalmia syndrome	DACH1 HESX1	2.07e-03	21	95	2	cv:C5680330
Disease	age of onset of asthma	RUNX1 UBAP2L RERE	2.14e-03	79	95	3	OBA_2001001
Disease	alcohol consumption measurement	PIGN TCF7L2 WASF3 NPIPB8 NPIPB6 SETBP1 AUTS2 ASXL2 WDR90 RERE MGA	2.16e-03	1242	95	11	EFO_0007878
Disease	cognitive function measurement	TCF7L2 NUP210L CNOT10 RBMS1 PTPRD PRRC2C KIAA1217 SETBP1 CYP26C1 AUTS2 CACNA1H ASXL2	2.18e-03	1434	95	12	EFO_0008354
Disease	dilated cardiomyopathy (biomarker_via_orthology)	DSC2 AXIN2	2.27e-03	22	95	2	DOID:12930 (biomarker_via_orthology)
Disease	irritability measurement	TCF7L2 CFAP77 AUTS2	2.38e-03	82	95	3	EFO_0009594
Disease	urate measurement	NRG1 TCF7L2 CD248 DACH1 ARID1A SETBP1 PIP5KL1 KDF1 NOTCH2	2.39e-03	895	95	9	EFO_0004531
Disease	serum albumin measurement	DOCK4 TCF7L2 MAP1A MLLT10 RUNX1 NYNRIN BSN	3.05e-03	592	95	7	EFO_0004535

Protein segments in the cluster

Peptide	Gene	Start	Entry
VDRPYPSSSPMHPCN	ATG13	216	O75143
PPNMTFGIRARPSTP	CFAP77	201	Q6ZQR2
TAMHLPPTLAAPGQP	CEBPE	151	Q15744
SAQPPAHQPPMISTK	CD248	506	Q9HCU0
AHLFTQDPAMPPLTP	AXIN2	676	Q9Y2T1
EGFPSPTIHPMSFSP	ERVV-2	141	B6SEH9
PSAMARSPTTHPPAN	AHDC1	951	Q5TGY3
SRPPMPAHPTPASIF	ANO9	761	A1A5B4
AHFLPQGTPTPLIPM	MT-ATP6	126	P00846
PSQGPQASITHPRMP	DACH1	391	Q9UI36
RLPGPFPQVAHPMSV	CECR2	931	Q9BXF3
GQVPPSPTLFSMHPT	DSC2	286	Q02487
IPVSRISPMPFHPSQ	ASXL2	621	Q76L83
ISPMPFHPSQVSPRA	ASXL2	626	Q76L83
QSLVPAHPMAPPSPS	RBMS1	26	P29558
PARMSPVDFHTPSSP	NRG1	431	Q02297
MPTAFPGLAPTSPHL	NR4A1	226	P22736
PHSRHTQIRPTMFPP	NSUN2	381	Q08J23
PRPPSGQSDSIMHPS	ARID1A	726	O14497
DINSAPMTHSPITPP	MUC16	1956	Q8WXI7
NPMLATAAPPAPVHA	NOTCH2	2181	Q04721
SPQMFHTVSPGPPSA	MBD6	131	Q96DN6
HPGPASQPPVSSATM	MBD6	281	Q96DN6
ATQVSMDHPPTGPPS	PIP5KL1	66	Q5T9C9
APMSVPEPHAATASP	MAP1A	1251	P78559
VQSPLHSPQSPPEGM	MAGEC1	656	O60732
ERTPVSHPQRMPAFP	KIAA1671	1711	Q9BY89
RHPSMPAFPALLPAA	NCKAP5L	1191	Q9HCH0
LGVPHNPAPPMSTVI	IFITM2	31	Q01629
PVRSPSGMNLFRHPN	MGA	1791	Q8IWI9
PALMFSPTQPGRPHT	MERTK	61	Q12866
AEVSLPMPAPQPSHS	LMTK3	106	Q96Q04
PSPMVAQGTQTPHRP	BSN	1526	Q9UPA5
EGFPSPTIHPMSFSP	ERVV-1	141	B6SEH8
MAVPPSAPQPRASFH	ETNK2	1	Q9NVF9
FPTDGTHPFVIQMRP	GRIA2	116	P42262
MVASHQSPLVSPDPP	PLXNB1	671	O43157
FEGVPMTHSPTDPRP	MYLK2	176	Q9H1R3
MGRQPPPPTQQHSIT	NPIPB8	261	E9PQR5
FPHAIPPTAIMPTPA	AUTS2	546	Q8WXX7
PSGISFPSVVDHPMP	HESX1	66	Q9UBX0
RTPAPFLHPTAAPAM	MYRFL	81	Q96LU7
NPPPSPATERSHYTM	LRP6	1486	O75581
HMRPSEPKPFSQPLN	FOXP4	371	Q8IVH2
NHASPSPVPEMPTLP	KIAA1549L	216	Q6ZVL6
RMGHQPPPPTQQHSI	NPIPA2	261	E9PIF3
HVPPSIAPGPTNMTV	HMCN1	3801	Q96RW7
HLVYSQAPPPPMTSA	CBLL1	366	Q75N03
FAPPPTPMVDHLVAS	PYGO2	61	Q9BRQ0
PHTPSPVFLMGANTQ	CD1E	341	P15812
PGPSLPTMNFVHTSP	IL37	36	Q9NZH6
DMRPTPNHTGCRPTP	GRM6	561	O15303
SFPPQEPRHSPQVKM	CABIN1	2026	Q9Y6J0
MQASPVHFPNGSPRV	DOCK4	1596	Q8N1I0
MALRGHPEPQPTNTP	LINC02908	1	Q6ZV77
PSSPQAPMPTTHPAR	FRS3	436	O43559
PHPLPAERPIFNSMA	CORO2A	406	Q92828
QKVNFVPPHPSSMPV	FLI1	396	Q01543
TPAFPAMQTVPIVHP	CYP26C1	486	Q6V0L0
FPTLLNGHMPVPIPS	ELK3	376	P41970
FPESHLRTPQMPPTT	IFI16	421	Q16666
APRTVLPFEAMPQHP	CYP11B2	31	P19099
SYMFRPVVPASAPHP	CACNA1H	1931	O95180
HVSSPPQALPPGTQM	SEC24C	246	P53992
MGRQPPPPTQQHSIT	NPIPB6	261	E9PJ23
TSSPPHFMSLQPPLA	NUP210L	1861	Q5VU65
TPAASMPRFFQVLPP	NYNRIN	1286	Q9P2P1
PRFSIPPTNHEIMPG	PTPRD	236	P23468
FQTPGMASHPPIPIL	PTPRD	1326	P23468
PLPSAPPRPAQHTTM	OTOG	1756	Q6ZRI0
PPRPAQHTTMATRSP	OTOG	1761	Q6ZRI0
LPFTPAAMTQAHPPT	OTOG	1861	Q6ZRI0
RTAMRVSPHHPAPTP	RUNX1	206	Q01196
APPATRESQKPPMAH	RTL3	116	Q8N8U3
HAQPQTTMAPRPATP	TAF4	481	O00268
GSHLPPQPTSTMNPS	TRIM33	706	Q9UPN9
VQPSQLGHIFMPPSP	TAB3	311	Q8N5C8
PHTNTFPAPVQRPPM	PRRC2C	2746	Q9Y520
PSQPPPVGTSAIHMS	KIAA1217	631	Q5T5P2
GHMRPSFEPPPTTIA	RERE	1226	Q9P2R6
PPMRHSLPSTFASSP	KDF1	196	Q8NAX2
QPAAPAVPMNAPALH	DZIP1	466	Q86YF9
TTVPPNATHPMPATL	MLLT10	936	P55197
PVHPIQPIQMPAFTT	CNOT10	726	Q9H9A5
AQPTPPMPTRPVSFH	PKP3	151	Q9Y446
FPMPATTETQGHLPP	WDR90	1621	Q96KV7
PATAAAYPPAPFMHI	UBAP2L	1021	Q14157
TSAHSPAQAPMPVPA	SPEM3	326	A0A1B0GUW6
TMGQPRTPHSPPLAK	TNS4	341	Q8IZW8
ATFPQGPSMERRHPV	SPINT1	316	O43278
PPQPTHMAPLGQFVS	RNF44	191	Q7L0R7
VNASMSRFPPHMVPP	TCF7L2	286	Q9NQB0
PMQPPFPASASSTHA	WASF3	366	Q9UPY6
CRTFMPPRVTHPDPT	TMEM79	156	Q9BSE2
SPLVHGMTPQFTPLP	PIGN	26	O95427
RSSCPADYPMPPNIH	ZC3H12B	671	Q5HYM0
PAPHQPPAASRSMFV	TNFSF11	36	O14788
PPHAQGALLSPPVSM	TOX2	391	Q96NM4
PSEAPSPMPTHRSYL	SLC6A17	681	Q9H1V8
MRPTVPPPQFHTNSH	SETBP1	1086	Q9Y6X0
MLPTEVPQSHPGPSA	VWA7	1	Q9Y334
PPAPRHQEMASASPF	ZNF500	201	O60304
QDMPPHLPTASASFP	NEUROD1	201	Q13562